CompanyGraph
At a glance
- Depends onMidstream position: 5 outgoing, 4 incoming connections
- ScaleMarket cap is $151.31M, lower than 95% of all stocks globally
- FinancialsAltman Z-Score 1.88: grey zone
Sign in to view price data.
Sign inThe reported statements, read against the company's own industry.
Financials view
Market Capitalization
214.35BKRW151.31M · vs all stocks (USD)
Revenue (TTM)
179.50BKRW126.71M · vs all stocks (USD)
Profit Margin
-3.26%Beta
0.7150xvs all stocks
52-Week Change
-47.44%vs all stocks
Market Capitalization
214.35BKRW151.31M · vs all stocks (USD)
Enterprise Value
225.03BKRW158.85M · vs all stocks (USD)
Price to Sales (TTM)
1.17xPrice to Book (MRQ)
2.41xEnterprise to Revenue
1.25xGross Margin
28.23%Profit Margin
-3.26%Operating Margin
-6.65%Return on Assets (TTM)
-1.83%Return on Equity (TTM)
-4.98%Revenue (TTM)
179.50BKRW126.71M · vs all stocks (USD)
Revenue per Share (TTM)
1.00KKRWUpdated Jul 14, 2026Quarterly Revenue Growth
-16.00%Gross Profit (TTM)
57.75BKRW40.76M · vs all stocks (USD)
EBITDA (TTM)
8.67BKRW6.12M · vs all stocks (USD)
Net Income (TTM)
-5.84BKRW-4.13M · vs all stocks (USD)
Quarterly Earnings Growth (YoY)
-0.49%Operating Cash Flow (TTM)
3.28BKRW2.31M · vs all stocks (USD)
Levered Free Cash Flow (TTM)
-3.33BKRW-2.35M · vs all stocks (USD)
Payout Ratio
0.00%Revenue
254.26BKRWFY2025 · Dec 31, 2025Cost of Goods Sold
177.10BKRWFY2025 · Dec 31, 2025Gross Profit
77.16BKRWFY2025 · Dec 31, 2025Operating Income
4.82BKRW3.40M · vs all stocks (USD)
Pre-tax Income
-212.00MKRWFY2025 · Dec 31, 2025Income Tax Expense
15.66MKRWFY2025 · Dec 31, 2025Net Income
-227.66MKRWFY2025 · Dec 31, 2025EBIT
3.97BKRWFY2025 · Dec 31, 2025EBITDA (Income Statement)
12.68BKRWFY2025 · Dec 31, 2025Research & Development
10.30BKRWFY2025 · Dec 31, 2025Selling, General & Administrative
29.75BKRWFY2025 · Dec 31, 2025Other Operating Expenses
-803.01MKRWFY2025 · Dec 31, 2025Non-operating Interest Income
149.46MKRWFY2025 · Dec 31, 2025Non-operating Interest Expense
4.18BKRWFY2025 · Dec 31, 2025Net Income from Continuing Operations
-227.66MKRWFY2025 · Dec 31, 2025Operating Cash Flow
-1.33BKRWFY2025 · Dec 31, 2025Free Cash Flow
-12.26BKRWFY2025 · Dec 31, 2025Cash & Cash Equivalents (End of Period)
28.43BKRWFY2025 · Dec 31, 2025Starting Profit (CF Statement)
-227.66MKRWFY2025 · Dec 31, 2025Other Non-cash Items
5.16BKRWFY2025 · Dec 31, 2025Change in Accounts Receivable (CF)
-2.45BKRWFY2025 · Dec 31, 2025Change in Other Assets/Liabilities
-3.81BKRWFY2025 · Dec 31, 2025Capital Expenditures
-10.92BKRWFY2025 · Dec 31, 2025Net Intangibles (CF)
-779.43MKRWFY2025 · Dec 31, 2025Other Investing Activity
-202.00MKRWFY2025 · Dec 31, 2025Net Investing Cash Flow
-11.13BKRWFY2025 · Dec 31, 2025Long-term Debt Issuance
52.60BKRWFY2025 · Dec 31, 2025Long-term Debt Payments
-50.16BKRWFY2025 · Dec 31, 2025Net Short-term Debt Issuance
0.00KRWFY2025 · Dec 31, 2025Other Financing Charges
-10.00KRWFY2025 · Dec 31, 2025Net Financing Cash Flow
2.44BKRWFY2025 · Dec 31, 2025Shares Outstanding
182.89MSharesUpdated Jul 14, 2026Float Shares
86.92MSharesUpdated Jul 14, 2026% Held by Insiders
52.46%vs all stocks
% Held by Institutions
2.02%vs all stocks
Total Cash (MRQ)
7.17BKRW5.06M · vs all stocks (USD)
Total Cash per Share (MRQ)
39.19KRWUpdated Jul 14, 2026Current Ratio (MRQ)
2.96xBook Value per Share (MRQ)
485.57KRWUpdated Jul 14, 2026Total Assets
262.38BKRW185.22M · vs all stocks (USD)
Total Current Assets
145.63BKRWFY2025 · Dec 31, 2025Total Liabilities
170.93BKRWFY2025 · Dec 31, 2025Total Non-current Assets
116.75BKRWFY2025 · Dec 31, 2025Total Non-current Liabilities
72.42BKRWFY2025 · Dec 31, 2025Total Current Liabilities
98.51BKRWFY2025 · Dec 31, 2025Cash
28.43BKRWFY2025 · Dec 31, 2025Cash & Cash Equivalents
28.43BKRWFY2025 · Dec 31, 2025Accounts Receivable
48.81BKRWFY2025 · Dec 31, 2025Inventory
66.18BKRWFY2025 · Dec 31, 2025Accounts Payable
22.87BKRWFY2025 · Dec 31, 2025Short-term Debt
44.80BKRWFY2025 · Dec 31, 2025Other Current Liabilities
1.30BKRWFY2025 · Dec 31, 2025Long-term Debt
49.19BKRWFY2025 · Dec 31, 2025Other Non-current Liabilities
3.82BKRWFY2025 · Dec 31, 2025Common Stock (Book)
91.45BKRWFY2025 · Dec 31, 2025Retained Earnings
-19.12BKRWFY2025 · Dec 31, 2025Total Shareholders' Equity
91.46BKRW64.56M · vs all stocks (USD)
52-Week Low
1.08KKRWUpdated Jul 14, 202652-Week High
2.33KKRWUpdated Jul 14, 202652-Week Change
-47.44%vs all stocks
Beta
0.7150xvs all stocks
50-Day MA
1.36KKRWUpdated Jul 14, 2026200-Day MA
1.78KKRWUpdated Jul 14, 2026Avg 10-Day Volume
227.40KSharesUpdated Jul 14, 2026Avg 30-Day Volume
319.86KSharesUpdated Jul 14, 2026Diluted EPS (TTM)
-1.00KRWUpdated Jul 14, 2026Shared structure with peers — never a ranking.
Relationships view
Structural observations derived from financial data, industry benchmarks, and supply chain position.
Financial Health
Altman Z-Score 1.88: grey zoneSignificant
Altman Z-Score: 1.88
Supply Chain
Midstream position: 5 outgoing, 4 incoming connectionsNotable
Outgoing: 5.00Incoming: 4.00
Scale
Market cap is $151.31M, lower than 95% of all stocks globallySignificant
Market cap (USD): 151,309,634.003Global P5: 269,387,740.27
Companies that share the same coordination system — how they create, deliver, or capture value.
HLB Pharmaceutical Co., Ltd.
Tier 1ProductionApproval-Gated PipelineRuleFlow
EKF Diagnostics Holdings plc
Tier 1ProductionApproval-Gated PipelineRuleFlow
Enlivex Therapeutics Ltd.
Tier 1ProductionApproval-Gated PipelineRuleRisk
S Biomedics Co., Ltd.
Tier 1ProductionApproval-Gated PipelineRuleRisk
Chill Brands Group Plc
Tier 1ProductionApproval-Gated PipelineRuleFlow
Graphy Inc.
Tier 1ProductionApproval-Gated PipelineRule
Sensorion SA
Tier 1ProductionApproval-Gated PipelineRuleRisk
Mycenax Biotech Inc.
Tier 1ProductionApproval-Gated PipelineRuleFlow
Journey Medical Corp
Tier 1ProductionApproval-Gated PipelineRule
Alector Inc.
Tier 1ProductionApproval-Gated PipelineRule